- Sargent returns to US squad for pre-COPA friendlies
- Microsoft unveils 'Copilot Plus' PC amped with AI
- Biden slams 'outrageous' ICC bid to arrest Israeli leaders
- Five things to know about incoming Anfield boss Arne Slot
- Changing climate influences London's Chelsea Flower Show
- UK PM sorry for institutional cover-up in infected blood scandal
- G7 push to use Russian assets for Ukraine 'vital and urgent': Yellen
- Trump trial closing arguments set for next week
- US Supreme Court rejects ex-Guantanamo detainee's appeal
- Japan's Studio Ghibli receives honorary Palme d'Or in Cannes
- Liverpool confirm Slot will replace Klopp as manager
- Pogacar 'good enough' to win Giro d'Italia and Tour de France
- Cargo ship that destroyed Baltimore bridge towed to port
- 'God works slowly': NGO ship rescues 35 Bangladeshis off Malta
- Dominican Republic's President Abinader wins resounding re-election
- England relish 'fear factor' of returning paceman Archer
- Israel, Hamas reject bid before ICC to arrest leaders for war crimes
- Explosive Trump biopic hits Cannes Film Festival
- Demi Moore transforms for Cannes body horror 'The Substance'
- Spain demands Milei public apology for 'corrupt wife' comment
- Gold hits record high as Iran shock triggers haven support
- Ship that destroyed Baltimore bridge being towed to port
- Max wins but Red Bull supremacy challenged: Emilia Romagna GP talking points
- US inflation fight will take 'further time': senior Fed official
- UK report finds cover-up of decades-long infected blood scandal
- Trump trial resumes, closing arguments expected next week
- Ruto on first state visit by Kenyan leader to US in two decades
- African players in Europe: Superb Kudus goal in vain as City take title
- Pope to visit Belgium, Luxembourg in September
- Gold hits high as Iran shock triggers haven support
- Strikes pound Gaza as Israel voices 'duty' to expand Rafah incursion
- Russia tries playwright and director on terror charges
- Iran mourns president Raisi's death in helicopter crash
- Attack on tourists rocks fledgling Afghanistan tourism sector
- Paralympics should put disability back on global agenda, says IPC chief
- South Africa's top court strikes Zuma from ballot
- Crunch time looms for BHP's bid buy Anglo American
- Kane to face old club Spurs for first time in Seoul
- Markets rise as traders cheered by China property plan
- Black farmers in Brazil changing views on coffee production
- Iran's President Raisi declared dead in helicopter crash
- Australia police arrest 554 in domestic violence crackdown
- South Korea, Britain host AI summit with safety top of agenda
- New president Lai vows to defend Taiwan's democracy
- Forever fad: Rubik says his cube 'reminds us why we have hands'
- Trump eyes witness stand as trial draws to a close
- Ryanair annual profit jumps on higher demand, fares
- High-priced Cummins, Starc face off as IPL enters playoffs
- Iran media says President Raisi died in helicopter crash
- Dominican Republic President Abinader re-elected to 2nd term
CMSD | 0.21% | 24.22 | $ | |
RBGPF | -2.33% | 56.32 | $ | |
CMSC | 0.02% | 24.4774 | $ | |
BCC | 1.19% | 137.695 | $ | |
SCS | -1.64% | 13.41 | $ | |
BCE | -0.94% | 34.02 | $ | |
JRI | 0.25% | 11.609 | $ | |
NGG | -0.43% | 72.52 | $ | |
RIO | -0.37% | 73.335 | $ | |
GSK | -0.41% | 44.795 | $ | |
RELX | 0.13% | 44.127 | $ | |
AZN | 0.34% | 77.16 | $ | |
RYCEF | 3.94% | 5.515 | $ | |
BTI | -0.61% | 31.399 | $ | |
BP | -0.43% | 37.33 | $ | |
VOD | -0.15% | 9.775 | $ |
French, US drug firms team up for Covid-flu shot
French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.
Under a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax's Covid-19 vaccine worldwide, except in some countries including India, Japan and South Korea, where the US firm already has partnership agreements.
Novavax will receive an upfront payment of $500 million and up to $700 million if it reachers certain milestones while Sanofi will take a five percent stake in the US company.
Sanofi will book sales of Novavax's protein-based Covid-19 vaccine from 2025.
The French group will be able to develop a combination flu-Covid vaccine using its own flu shots with the US company's Covid jab.
The announcement comes as pharmaceutical companies have reported drops in sales for Covid vaccines.
Novavax, which is highly dependent on its Covid vaccine, raised doubts last year about its ability to continue its business.
The Maryland-based firm was an early frontrunner in the global vaccine race, but fell behind after being hit by manufacturing and regulatory delays.
For Sanofi, the deal is a chance to develop a combination flu-Covid jab.
"With flu and Covid-19 hospital admission rates now closely mirroring each other, we have an opportunity to develop non-mRNA flu-Covid-19 combination vaccines offering patients both enhanced convenience and protection against two serious respiratory viruses," said Jean-Francois Toussaint, Sanofi's global head of vaccine research and development.
A.Gasser--BTB